XML 65 R10.htm IDEA: XBRL DOCUMENT
v3.19.3

Acquisitions | 9 Months Ended
--- | ---
Sep. 30, 2019
Acquisition Disclosure [Abstract] |
Acquisitions Disclosure [Text Block] | 4. Acquisition On January 31, 2018, the Company acquired all of the issued and outstanding shares of Data Sciences International, Inc. (DSI), a Delaware corporation, for approximately $7 1.1 million. The Company funded the acquisition from its existing cash balances, excess proceeds from the Denville Transaction discus sed in Note 5, and proceeds from the Financing Agreement discussed in Note 14. DSI, a St. Paul, Minnesota-based life science research company, is a recognized leader in physiologic monitoring focused on delivering preclinical products, systems, services and solutions to its customers. Its customers include pharmaceutical and biotechnology companies, as well as contract research organizations, academic labs and government researchers. This acquisition diversifies the Company’s customer base into the biopha rmaceutical and contract research organization markets. The results of operations for DSI have been included in the Company’s consolidated financial statements from the date of acquisition. Included in the net loss for the nine months ended September 30, 2018 was a $3.8 million charge recognized in cost of revenues related to purchase accounting inventory fair value step up amortization. The total inventory fair value step up was recognized into cost of revenues over one inventory turn, or approxi mately five and a half months. Also included in the net los s of DSI for that period was $2.9 million of intangible asset amortization expense. The following consolidated pro forma information is based on the assumption that was used at the time of the acquisition of DSI. Accordingly, the historical results have b een adjuste d to reflect amortization expense, interest expense and other purchase accounting adjustments that would have been recognized on such a pro forma basis. The pro forma information is presented for comparative purposes only and is not necessarily indicative of the financial position or results of operations which would have been reported had the Company completed the acquisition during these periods or which might be reported in the future.
|  | Nine Months Ended |
|  | September 30, |
|  | 2018 |
|  | (in thousands) |
| Pro Forma |  |  |
| Revenues | $ | 90,384 |
| Income (loss) from continuing operations |  | (236) |
Direct acquisition costs recorded in other expense, net in the Company’s consolidated statements of operations were $3.0 million f or the nine months ended September 30, 2018.

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationDescriptionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -URI http://asc.fasb.org/topic&trid=2303972 + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration